期刊文献+

NF-κB: A novel therapeutic pathway for gastroesophageal reflux disease? 被引量:8

暂未订购
导出
摘要 Although gastroesophageal reflux disease(GERD),a common chronic disease in clinical practice,has been widely studied,its potential adverse impact on patients is still a significant clinical concern.It is necessary to understand the pathogenesis of the disease and choose appropriate treatment according to its mechanism.The pathogenesis of GERD is diverse and complex.As the traditional treatment methods are expensive and ineffective in alleviating symptoms in some patients,new treatment options need to be explored.Our previous study suggested that the activation of nuclear factor-kappa beta(NF-κB)in esophageal mucosa may be related to the injury of epithelial barrier function caused by reflux.Based on the literature and our previous study results,it is speculated that inhibition of NF-κB activation may block the insult of GERD on the esophageal mucosal barrier.NF-κB may play an important role in the development of GERD.This article reviews the pathogenesis of GERD and the relationship between NF-κB and GERD,in order to provide new strategies for the treatment of GERD.
出处 《World Journal of Clinical Cases》 SCIE 2022年第24期8436-8442,共7页 世界临床病例杂志
  • 相关文献

同被引文献119

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部